Web Exclusives

Teach-back: An underutilized tool

In an effort to encourage nurses to use the teach-back method when educating patients, we conducted a literature review on the topic of patient…
preventing harm 1

ANA on the Frontline, May 2019

Learn about the top issues facing ANA member nurses, how ANA is working for you, and what ANA is doing to advance nursing. In…

May 2019 Vol. 14 No. 5

This issue includes two articles with so much information that we had to break them into two parts. The first is a feature titled…

FDA approves medical device for ADHD

On April 19, the FDA permitted marking of the first medical device to treat attention deficit hyperactivity disorder (ADHD): Monarch external Trigeminal Nerve Stimulation…

Teach-back: An underutilized tool

In an effort to encourage nurses to use the teach-back method when educating patients, we conducted a literature review on the topic…

May 2019 Vol. 14 No. 5

This issue includes two articles with so much information that we had to break them into two parts. The first is a…

FDA approves medical device for ADHD

On April 19, the FDA permitted marking of the first medical device to treat attention deficit hyperactivity disorder (ADHD): Monarch external Trigeminal…

Test Your Knowledge

Which of the following best describes Wegovy’s FDA-approved use?

cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • This field is hidden when viewing the form

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.